Where is the fun in that? A systematic review of user evaluation of game-based cognitive assessment for older people
ABSTRACT
Background:
Game based cognitive assessments (GBCAs) have the potential to transform the field of cognitive testing by enabling more effective screening of age-related cognitive decline. However, we lack a strong understanding of the usability and overall user experience of these games. This is a risk because the primary target users for GBCAs, older people, are seldom involved in game design research and development.
Objective:
This review attempts to address this gap by investigating the usability, acceptability and enjoyability of GBCAs for older people.
Methods:
This study followed established practices for undertaking evidence-based systematic reviews.
Results:
The initial database search returned 15,232 records. After a thorough screening process, eight studies remained for extraction and analysis. A synthesis of the included papers identified two overlapping yet distinct areas of focus: system usability and subjective user experience. Usability scores were mostly positive across the studies included. However, in several of the game studies, older and cognitively impaired participants tended to find GBCAs less usable. This trend was found even when games were explicitly designed for older and impaired users, and tasks were simplistic and representative of basic daily activities. In our second focus area, user experience, we identified the importance of perceived challenge in mediating gameplay experience across groups. That is, getting the difficulty level just right seems essential to a good user experience, specifically enjoyment.
Conclusions:
Through this review we have identified key learnings for researchers interested in designing and developing GBCAs. These include: (a) validity is very necessary but not sufficient; (b) clarify the intended user; (c) create games that align with the unique preferences and needs of older people; and (d) wherever possible, always provide each user their optimal challenge. Clinical Trial: Prospero ID: CRD42023433298
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.